Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

920 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol.
Ninomiya T, Ishikawa N, Inoue K, Kubo T, Yasugi M, Shibayama T, Maeda T, Fujitaka K, Kodani M, Yokoyama T, Kuyama S, Ochi N, Ueda Y, Miyoshi S, Kozuki T, Amano Y, Kubota T, Sugimoto K, Bessho A, Ishii T, Watanabe K, Oze I, Hotta K, Kiura K. Ninomiya T, et al. Among authors: amano y. Clin Lung Cancer. 2019 Mar;20(2):134-138. doi: 10.1016/j.cllc.2018.10.008. Epub 2018 Nov 1. Clin Lung Cancer. 2019. PMID: 30514667
Ability of the Glasgow Prognostic Score to predict the tolerability and efficacy of platinum-combination chemotherapy among elderly patients with advanced non-small cell lung cancer.
Nakashima K, Hata K, Hotta T, Tanaka S, Mitarai Y, Okuno T, Tanino A, Nakao M, Amano Y, Hamaguchi M, Okimoto T, Hamaguchi S, Nagao T, Kurimoto N, Isobe T, Tsubata Y. Nakashima K, et al. Among authors: amano y. J Med Invest. 2021;68(3.4):260-264. doi: 10.2152/jmi.68.260. J Med Invest. 2021. PMID: 34759141 Free article.
Phase II study of carboplatin plus weekly paclitaxel with bevacizumab for non-squamous, non-small cell lung cancer with idiopathic interstitial pneumonia (Hanshin Cancer Group IP002).
Katakami N, Nagata K, Nakakura A, Okamoto T, Kaneda T, Oki M, Watanabe K, Tokito T, Amano Y, Tamiya M, Morita S, Hatachi Y. Katakami N, et al. Among authors: amano y. Jpn J Clin Oncol. 2025 Jan 8;55(1):67-74. doi: 10.1093/jjco/hyae132. Jpn J Clin Oncol. 2025. PMID: 39311098 Clinical Trial.
Successful rechallenge with ceritinib after leukocytoclastic vasculitis during ceritinib treatment for non-small cell lung cancer harboring the EML4-ALK fusion protein.
Okimoto T, Tsubata Y, Hotta T, Hamaguchi M, Okuno T, Shiratsuki Y, Kodama A, Nakao M, Amano Y, Hamaguchi S, Kurimoto N, Tobita R, Isobe T. Okimoto T, et al. Among authors: amano y. Oncotarget. 2018 Apr 13;9(28):20213-20218. doi: 10.18632/oncotarget.24765. eCollection 2018 Apr 13. Oncotarget. 2018. PMID: 29732013 Free PMC article.
Prospective clinical trial evaluating vulnerability and chemotherapy risk using geriatric assessment tools in older patients with lung cancer.
Tsubata Y, Shiratsuki Y, Okuno T, Tanino A, Nakao M, Amano Y, Hotta T, Hamaguchi M, Okimoto T, Hamaguchi S, Kurimoto N, Nishiyama Y, Kimura T, Iwata H, Tsumoto S, Isobe T. Tsubata Y, et al. Among authors: amano y. Geriatr Gerontol Int. 2019 Nov;19(11):1108-1111. doi: 10.1111/ggi.13781. Geriatr Gerontol Int. 2019. PMID: 31746525 Free PMC article. Clinical Trial.
920 results